Safety study of MCAM in healthy adults
Part of Mental health clinical trials.
This early-stage safety trial tests a new experimental medication called MCAM in healthy volunteers. Researchers will measure how well the body tolerates the drug and how it moves through your system, to ensure it's safe before later testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- Your body mass index (BMI) is between 18.0 and 32.0, and you weigh at least 110 pounds
- You have not smoked or used any tobacco products for at least 3 months
- Your blood pressure, heart rate, and heart rhythm (ECG) are normal
- Your blood work and urine tests are normal
- You have not been in another drug trial within 30 days (or longer if the previous drug stays in your body longer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new approach for opioid use disorder in adults. It aims to understand safety and how the treatment may work in people with opioid addiction.
This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
This study looks at how a new drug is processed by the body in healthy adults. It will help understand how the drug is absorbed, distributed, and eliminated.
This early-stage trial tests how safe and tolerable CMS-D008, an experimental weight-management medicine, is in healthy adults who are overweight or obese. Researchers will gradually increase the dose to find the right amount and monitor how your body responds.
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.